Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60 | -2,092 | -1,766 | -1,509 | -657 |
| Depreciation Amortization | 22 | 90 | 68 | 46 | 23 |
| Accounts receivable | -143 | -35 | -334 | -109 | -87 |
| Accounts payable and accrued liabilities | 239 | -583 | -533 | -535 | -103 |
| Other Working Capital | -192 | -1,058 | -1,386 | -889 | -412 |
| Other Operating Activity | 100 | 1,611 | 1,604 | 1,164 | 472 |
| Operating Cash Flow | $-34 | $-2,067 | $-2,348 | $-1,832 | $-763 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | N/A | N/A | -11 | N/A |
| Investing Cash Flow | $-22 | $N/A | $0 | $-11 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 773 | 773 | N/A |
| Debt Repayment | N/A | N/A | -773 | -773 | N/A |
| Common Stock Issued | 4 | 4,167 | 4,151 | 4,151 | 454 |
| Other Financing Activity | -30 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-26 | $4,167 | $4,151 | $4,151 | $454 |
| Beginning Cash Position | 5,226 | 3,126 | 3,126 | 3,126 | 3,126 |
| End Cash Position | 5,145 | 5,226 | 4,929 | 5,435 | 2,817 |
| Net Cash Flow | $-81 | $2,100 | $1,803 | $2,309 | $-310 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34 | -2,067 | -2,348 | -1,832 | -763 |
| Capital Expenditure | -22 | N/A | 0 | -11 | 0 |
| Free Cash Flow | -55 | -2,067 | -2,348 | -1,842 | -763 |